Biden will begin his presidency in the midst of a global public health crisis that’s already killed over 240,000 people in the US alone. His team is already planning how to get COVID-19 under control.
Academic rigour, journalistic flair
Articles on Vaccines
Displaying 441 - 460 of 782 articles
Watch two of Australia and New Zealand’s top vaccine and virus experts answering questions about COVID-19. This was filmed at a Conversation reader event with Avid Reader bookshop.
Interim analysis of trial data isn’t unusual – but leaves us with many things we still need to find out.
With COVID-19 cases soaring across the US and worldwide, the need for a vaccine could not be greater. Here’s where we stand on vaccine development, including positive results from Pfizer’s trial.
Early analysis suggests this vaccine has an efficacy of over 90%. So if you took ten people who were going to get sick from COVID-19 and vaccinated them, only one would get sick.
Two more COVID-19 vaccines may now be on the cards for Australia, should they pass clinical trials. But, as with earlier vaccine deals, there are no guarantees.
The government has secured deals for two further COVID-19 vaccines, taking its portfolio of agreements to four.
A safe, effective COVID-19 vaccine is expected to be developed in record time and may be approved for production, distribution and acceptance some time in 2021.
Some have suggested the US allow healthy people to return to normal life, catch the coronavirus and get the population to herd immunity. The science says this plan is doomed to fail from the start.
Antibody levels naturally fade – the key question is whether infected people sustain adequate levels of T cells and B cells.
Any COVID-19 vaccine is likely to be given first to higher risk groups before it is given to children. But we still need vaccines that are safe and effective for them too.
With a vaccine, yes, elimination is possible. But we need to be realistic about how long this might take.
Delaying a widespread vaccination program would cause not only higher causalities but also long term economic loss for Indonesia.
Details are sketchy. But it looks like people would still need to go through the legal system to get compensation. There are better ways.
A COVID-19 vaccine isn’t the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.
Experts from across The Conversation look at how COVID-19 vaccines will work, how they’re being tested and manufactured, and what challenges there will be to rolling them out.
As ready as you are to be done with COVID-19, it’s not going anywhere soon. A historian of disease describes how once a pathogen emerges, it’s usually here to stay.
These drugs may help slow or reverse immune system decline.
Vaccines work by teaching your immune system about new viruses. Your immune cells are very clever – they will remember what they learnt, and protect you if you encounter that virus in the future.
There are many scientific and ethical challenges ahead. But these types of trials have helped in the development of vaccines against a few diseases. Could they do the same for COVID-19?
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor of Biology, Rochester Institute of Technology
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Immunology, RMIT University
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Senior Lecturer; MD, Victoria University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
